Where Innovation Meets Implementation. Experience Europe's New Era of Therapeutic Manufacturing
Go beyond theory: Cutting-edge science, strategies, & digital tools to accelerate your journey from molecule to market for mAbs, Biologics, & ATMPs.
SAVE THE DATE & PLAN AHEAD | APRIL 27-30, 2026
Mark your calendars and secure your travel budget allocation for BioProcess International Europe 2026!
Stay tuned as we reveal speakers and programming announcements.
Advance Technologies. Accelerate Production. Transform Bioprocessing.
Ready to go beyond theory? The BioProcess International (BPI) Europe 2026 agenda is where innovation meets implementation. Get the blueprint to master complex modalities, scale your pipeline, and define the future of medicine.
Cell Line Development & Engineering
- Utilise advanced host cell engineering for hard-to-express proteins.
- Apply AI and machine learning for predictive clone selection and lab automation.
- Use multi-omics and NGS to design for stability and de-risk manufacturing.
- Engineer stable producer cell lines for viral vectors and novel modalities.
Cell Culture & Upstream Processing
- Implement digital twins, PAT, and AI for predictive control in multi-modal pipelines.
- Master intensification strategies, including N-1 perfusion and continuous manufacturing.
- Optimise media and raw material strategies to fine-tune product quality.
- Overcome upstream challenges for complex modalities (e.g., exosomes, viral vectors, ADCs).
Downstream Processing
- Adopt a flexible 'toolbox' approach to purify complex and non-platform molecules.
- Explore technologies beyond the column, such as membranes and magnetic beads.
- Integrate continuous downstream processes and automate buffer preparation.
- Embed sustainability with green chemistry principles and bio-based materials.
ATMP Development & Manufacturing
- Tackle the COGS crisis with process intensification and novel raw materials.
- Master phase-appropriate CMC and advanced analytics to de-risk clinical translation.
- Automate autologous manufacturing and scale allogeneic & in-vivo therapies.
- Develop scalable manufacturing for non-viral delivery platforms.
*NEW for 2026* Digital Biomanufacturing & Data-Driven Operations
- Build the data bedrock for Biopharma 4.0 by harmonising data across systems.
- Validate and deploy AI/ML models in a GMP environment for predictive control.
- Build trustworthy digital twins using in-line sensors and physics-informed AI.
- Create a digital roadmap to future-proof your organisation.
Upskill with Pre-Conference Workshops
Deepen your expertise with our full-day workshops designed for practical, hands-on learning.
- Intensified & Continuous Processing
- Mastering Drug Product Formulation & Fill-Finish
- CMC Roadmap
- More to be announced...
Meet Europe's Leaders Preparing You For Tomorrow's Challenges
Our speaker faculty represents the brightest minds from global pharma, innovative biotechs, and pioneering academic institutions. Expect visionary keynotes, deep-dive case studies, and practical insights designed to help you go beyond theory. Learn directly from the experts who are turning today's innovations into tomorrow's reality.
BPI Europe Returns to Vienna - Where Science Meets Opportunity
Join us as we return to Vienna, a globally recognized meeting destination and one of Europe's premier life science hubs. The city is home to the renowned Vienna BioCenter, a nexus of academic research and over 50 innovative biotech companies, alongside industry leaders like Boehringer Ingelheim, Takeda and Novartis. This powerful combination of scientific excellence, seamless accessibility, and rich cultural heritage provides the ideal backdrop to connect with global pioneers and forge the collaborations that will drive the future of bioprocessing.
Get a feel for the buzz on-site!
BioProcess International Europe gathers today's top scientists and suppliers working across the entire spectrum of biopharmaceutical development and production.
Watch the highlight video from BPI Europe 2025 in Hamburg and see why we are Europe's leading bioprocessing event for mAbs, novel modalities & biologics.
Audience Breakdown
%
of attendees are coming from top Pharma & Biotech companies
of the top 20 pharma companies are sending representatives
%
of attendees hold VP-level and higher titles, fostering high-level discussions
Engage Qualified Bioprocessing Decision-Makers!
Whether you're increasing your company profile, launching a new product, or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us directly at Partners@informaconnectls.com